Frances Rachel Frankenburg, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Borderline Personality Disorder | 101 | 2024 | 767 | 7.020 |
Why?
|
Personality Disorders | 36 | 2024 | 729 | 2.120 |
Why?
|
Clozapine | 20 | 2019 | 509 | 1.760 |
Why?
|
Antipsychotic Agents | 13 | 2022 | 3081 | 1.140 |
Why?
|
Thiamine Deficiency | 2 | 2008 | 48 | 0.600 |
Why?
|
Self Concept | 4 | 2018 | 1046 | 0.510 |
Why?
|
Schizophrenia | 13 | 2022 | 6987 | 0.500 |
Why?
|
Psychiatric Status Rating Scales | 41 | 2020 | 6031 | 0.500 |
Why?
|
Defense Mechanisms | 3 | 2013 | 180 | 0.480 |
Why?
|
Follow-Up Studies | 55 | 2024 | 39394 | 0.410 |
Why?
|
Psychotic Disorders | 14 | 2019 | 3279 | 0.380 |
Why?
|
Self Mutilation | 6 | 2013 | 57 | 0.370 |
Why?
|
Comorbidity | 31 | 2024 | 10591 | 0.350 |
Why?
|
Health Status | 6 | 2024 | 4095 | 0.340 |
Why?
|
Interpersonal Relations | 11 | 2019 | 1438 | 0.340 |
Why?
|
Korsakoff Syndrome | 1 | 2008 | 18 | 0.310 |
Why?
|
Phenothiazines | 1 | 2008 | 60 | 0.300 |
Why?
|
Chlorpromazine | 1 | 2008 | 111 | 0.300 |
Why?
|
Neurosyphilis | 1 | 2008 | 27 | 0.300 |
Why?
|
One-Carbon Group Transferases | 1 | 2007 | 6 | 0.290 |
Why?
|
Psychotherapy | 6 | 2023 | 1654 | 0.280 |
Why?
|
Self-Assessment | 2 | 2009 | 400 | 0.280 |
Why?
|
Adult | 118 | 2024 | 223818 | 0.270 |
Why?
|
Prescription Drugs | 1 | 2014 | 635 | 0.270 |
Why?
|
Neutrophils | 1 | 2019 | 3785 | 0.270 |
Why?
|
Depressive Disorder | 16 | 2009 | 3726 | 0.270 |
Why?
|
Human Development | 1 | 2007 | 123 | 0.270 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2189 | 0.270 |
Why?
|
Malaria, Cerebral | 1 | 2008 | 136 | 0.270 |
Why?
|
Child Abuse | 9 | 2019 | 1097 | 0.260 |
Why?
|
Severity of Illness Index | 13 | 2024 | 15955 | 0.260 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 16 | 2013 | 1989 | 0.260 |
Why?
|
Alcoholism | 3 | 2023 | 1981 | 0.260 |
Why?
|
Temperament | 3 | 2024 | 301 | 0.250 |
Why?
|
Affective Symptoms | 2 | 2007 | 418 | 0.250 |
Why?
|
Lead Poisoning | 1 | 2008 | 323 | 0.240 |
Why?
|
Folic Acid | 2 | 2009 | 1336 | 0.240 |
Why?
|
Somatoform Disorders | 2 | 2007 | 425 | 0.240 |
Why?
|
Depressive Disorder, Major | 5 | 2023 | 4819 | 0.240 |
Why?
|
Suicide | 6 | 2019 | 1606 | 0.230 |
Why?
|
Women's Health | 2 | 2011 | 2081 | 0.230 |
Why?
|
Hyperthermia, Induced | 1 | 2008 | 416 | 0.230 |
Why?
|
Humans | 155 | 2024 | 768887 | 0.220 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2005 | 298 | 0.220 |
Why?
|
Social Adjustment | 4 | 2012 | 636 | 0.220 |
Why?
|
Bupropion | 1 | 2005 | 304 | 0.220 |
Why?
|
Aggression | 6 | 2017 | 750 | 0.220 |
Why?
|
Bipolar Disorder | 9 | 2008 | 5131 | 0.210 |
Why?
|
Female | 118 | 2024 | 397464 | 0.210 |
Why?
|
Longitudinal Studies | 23 | 2024 | 14795 | 0.210 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 3837 | 0.210 |
Why?
|
Remission Induction | 9 | 2024 | 2411 | 0.210 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2005 | 492 | 0.200 |
Why?
|
Male | 103 | 2024 | 365249 | 0.190 |
Why?
|
Depersonalization | 2 | 2020 | 40 | 0.190 |
Why?
|
Suicide, Attempted | 5 | 2019 | 1409 | 0.190 |
Why?
|
Valproic Acid | 3 | 2002 | 444 | 0.190 |
Why?
|
Pirenzepine | 1 | 2001 | 116 | 0.190 |
Why?
|
Prospective Studies | 34 | 2024 | 54950 | 0.180 |
Why?
|
Personality | 3 | 2019 | 560 | 0.180 |
Why?
|
Antimalarials | 1 | 2008 | 908 | 0.180 |
Why?
|
Psychotropic Drugs | 4 | 2015 | 883 | 0.180 |
Why?
|
England | 1 | 2021 | 533 | 0.170 |
Why?
|
Sexual Partners | 2 | 2016 | 807 | 0.170 |
Why?
|
Gastric Bypass | 1 | 2008 | 824 | 0.170 |
Why?
|
Time Factors | 15 | 2019 | 40266 | 0.170 |
Why?
|
Cognition Disorders | 5 | 2017 | 3985 | 0.170 |
Why?
|
Leukocyte Count | 3 | 2019 | 1609 | 0.170 |
Why?
|
Tobacco Use Disorder | 1 | 2005 | 708 | 0.170 |
Why?
|
Recurrence | 15 | 2024 | 8512 | 0.170 |
Why?
|
Young Adult | 32 | 2024 | 60110 | 0.170 |
Why?
|
Health Services | 1 | 2004 | 755 | 0.160 |
Why?
|
Stress Disorders, Post-Traumatic | 7 | 2024 | 4642 | 0.160 |
Why?
|
Interview, Psychological | 8 | 2016 | 810 | 0.160 |
Why?
|
Neuroleptic Malignant Syndrome | 3 | 1995 | 74 | 0.160 |
Why?
|
Eicosapentaenoic Acid | 1 | 2003 | 565 | 0.160 |
Why?
|
Identity Crisis | 2 | 2009 | 12 | 0.160 |
Why?
|
Prevalence | 16 | 2024 | 15875 | 0.150 |
Why?
|
Bulimia | 4 | 1990 | 405 | 0.150 |
Why?
|
Child Abuse, Sexual | 9 | 2010 | 404 | 0.150 |
Why?
|
Personality Assessment | 4 | 2019 | 646 | 0.150 |
Why?
|
Personality Development | 3 | 2005 | 242 | 0.150 |
Why?
|
Chronic Disease | 5 | 2013 | 9384 | 0.150 |
Why?
|
Delayed-Action Preparations | 1 | 2022 | 969 | 0.150 |
Why?
|
Patient Compliance | 2 | 2008 | 2701 | 0.150 |
Why?
|
Patient Education as Topic | 1 | 2008 | 2339 | 0.150 |
Why?
|
Edema | 1 | 2022 | 766 | 0.150 |
Why?
|
Lithium | 4 | 1991 | 600 | 0.150 |
Why?
|
Obesity | 3 | 2024 | 13087 | 0.150 |
Why?
|
Adolescent | 48 | 2020 | 89247 | 0.150 |
Why?
|
Dissociative Disorders | 3 | 2008 | 235 | 0.140 |
Why?
|
Mental Competency | 1 | 2018 | 179 | 0.130 |
Why?
|
Violence | 4 | 2012 | 936 | 0.130 |
Why?
|
Back Pain | 2 | 2014 | 547 | 0.130 |
Why?
|
Self Report | 3 | 2024 | 3773 | 0.130 |
Why?
|
Mental Disorders | 7 | 2012 | 6879 | 0.130 |
Why?
|
1-Naphthylamine | 2 | 1996 | 48 | 0.130 |
Why?
|
History, 20th Century | 5 | 2017 | 2771 | 0.130 |
Why?
|
Self-Injurious Behavior | 3 | 2013 | 568 | 0.120 |
Why?
|
Agranulocytosis | 1 | 1994 | 98 | 0.120 |
Why?
|
Hospitalization | 20 | 2019 | 10845 | 0.120 |
Why?
|
Mental Status Schedule | 1 | 2015 | 315 | 0.120 |
Why?
|
Crime Victims | 2 | 2012 | 347 | 0.120 |
Why?
|
Urination Disorders | 1 | 1996 | 238 | 0.120 |
Why?
|
Leukopenia | 1 | 1995 | 212 | 0.120 |
Why?
|
Anticonvulsants | 2 | 2002 | 1924 | 0.110 |
Why?
|
Smoking Cessation | 1 | 2005 | 2084 | 0.110 |
Why?
|
Shame | 1 | 2014 | 80 | 0.110 |
Why?
|
Choice Behavior | 2 | 2013 | 848 | 0.110 |
Why?
|
Respiration Disorders | 1 | 1996 | 365 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2003 | 1399 | 0.110 |
Why?
|
Social Behavior | 3 | 2011 | 1146 | 0.110 |
Why?
|
Osteoarthritis | 2 | 2014 | 1070 | 0.100 |
Why?
|
Interviews as Topic | 5 | 2014 | 2742 | 0.100 |
Why?
|
Commitment of Mentally Ill | 2 | 1982 | 93 | 0.100 |
Why?
|
Personality Inventory | 5 | 2006 | 1018 | 0.100 |
Why?
|
Marriage | 1 | 2014 | 351 | 0.100 |
Why?
|
Delirium | 1 | 2004 | 1696 | 0.100 |
Why?
|
Rehabilitation, Vocational | 2 | 2010 | 71 | 0.100 |
Why?
|
Tinnitus | 1 | 1994 | 197 | 0.100 |
Why?
|
Schizophrenic Psychology | 3 | 1994 | 1651 | 0.100 |
Why?
|
Spouses | 1 | 2014 | 286 | 0.100 |
Why?
|
Eosinophilia | 2 | 1995 | 556 | 0.090 |
Why?
|
Tourette Syndrome | 1 | 1994 | 400 | 0.090 |
Why?
|
Cognitive Dissonance | 1 | 2010 | 14 | 0.090 |
Why?
|
Impulsive Behavior | 4 | 2007 | 349 | 0.090 |
Why?
|
Rape | 4 | 2005 | 131 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2004 | 3800 | 0.090 |
Why?
|
Body Weight | 4 | 1998 | 4628 | 0.090 |
Why?
|
Middle Aged | 36 | 2024 | 223740 | 0.090 |
Why?
|
Trifluoperazine | 1 | 1990 | 40 | 0.090 |
Why?
|
Anorexia Nervosa | 3 | 2010 | 1364 | 0.080 |
Why?
|
Anxiety Disorders | 6 | 2012 | 2748 | 0.080 |
Why?
|
Drug Administration Schedule | 6 | 2014 | 4862 | 0.080 |
Why?
|
Projection | 1 | 2009 | 18 | 0.080 |
Why?
|
Fibromyalgia | 1 | 2014 | 407 | 0.080 |
Why?
|
Capgras Syndrome | 1 | 1989 | 10 | 0.080 |
Why?
|
Income | 2 | 2016 | 1878 | 0.080 |
Why?
|
Electroconvulsive Therapy | 1 | 2014 | 504 | 0.080 |
Why?
|
Social Security | 1 | 2009 | 101 | 0.080 |
Why?
|
Family Characteristics | 1 | 2014 | 1002 | 0.080 |
Why?
|
Diazepam | 1 | 1990 | 214 | 0.080 |
Why?
|
Porphyrias | 1 | 2008 | 57 | 0.080 |
Why?
|
Bread | 1 | 2008 | 23 | 0.080 |
Why?
|
Substance-Related Disorders | 10 | 2017 | 4429 | 0.080 |
Why?
|
S-Adenosylmethionine | 2 | 2007 | 219 | 0.080 |
Why?
|
Agnosia | 1 | 1989 | 66 | 0.080 |
Why?
|
Drug Therapy, Combination | 8 | 2004 | 6320 | 0.080 |
Why?
|
Treatment Outcome | 11 | 2018 | 65485 | 0.080 |
Why?
|
Gasoline | 1 | 2008 | 49 | 0.070 |
Why?
|
Massachusetts | 10 | 2014 | 8888 | 0.070 |
Why?
|
Irritable Bowel Syndrome | 1 | 2013 | 455 | 0.070 |
Why?
|
Bulimia Nervosa | 1 | 2010 | 208 | 0.070 |
Why?
|
Life Style | 2 | 2013 | 3931 | 0.070 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2593 | 0.070 |
Why?
|
Parent-Child Relations | 2 | 2000 | 773 | 0.070 |
Why?
|
Prognosis | 11 | 2019 | 30044 | 0.070 |
Why?
|
History, 19th Century | 2 | 2008 | 715 | 0.070 |
Why?
|
Fluoxetine | 3 | 2004 | 735 | 0.070 |
Why?
|
Carbamazepine | 1 | 1988 | 224 | 0.070 |
Why?
|
History, 21st Century | 2 | 2017 | 1575 | 0.070 |
Why?
|
Thiamine | 1 | 2008 | 160 | 0.070 |
Why?
|
Food, Fortified | 1 | 2008 | 189 | 0.070 |
Why?
|
Benzodiazepines | 2 | 2004 | 1139 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2008 | 15889 | 0.070 |
Why?
|
Sex Offenses | 1 | 2010 | 357 | 0.070 |
Why?
|
Life Change Events | 3 | 2012 | 962 | 0.070 |
Why?
|
Reproducibility of Results | 9 | 2015 | 20244 | 0.070 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 276 | 0.060 |
Why?
|
Neuropsychological Tests | 2 | 2017 | 7148 | 0.060 |
Why?
|
Double-Blind Method | 4 | 2003 | 12469 | 0.060 |
Why?
|
Europe | 2 | 2008 | 3441 | 0.060 |
Why?
|
Mental Health Services | 2 | 2010 | 1732 | 0.060 |
Why?
|
Paranoid Disorders | 3 | 2013 | 61 | 0.060 |
Why?
|
Sex Factors | 8 | 2010 | 10641 | 0.060 |
Why?
|
Antisocial Personality Disorder | 4 | 2012 | 224 | 0.060 |
Why?
|
Muscle Weakness | 1 | 2008 | 415 | 0.060 |
Why?
|
Pancreatitis | 1 | 1992 | 1087 | 0.060 |
Why?
|
Pilot Projects | 4 | 2003 | 8742 | 0.060 |
Why?
|
Fever | 2 | 1995 | 1620 | 0.060 |
Why?
|
Pain | 2 | 2023 | 5100 | 0.060 |
Why?
|
Australia | 1 | 2008 | 1265 | 0.060 |
Why?
|
Case-Control Studies | 6 | 2017 | 22294 | 0.060 |
Why?
|
Vitamin B 12 | 1 | 2007 | 528 | 0.060 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2013 | 1106 | 0.060 |
Why?
|
Homocysteine | 1 | 2007 | 637 | 0.060 |
Why?
|
Anxiety | 3 | 2014 | 4677 | 0.060 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2667 | 0.060 |
Why?
|
Obsessive Behavior | 1 | 1984 | 51 | 0.060 |
Why?
|
Child | 15 | 2019 | 80969 | 0.050 |
Why?
|
Family | 3 | 2009 | 3208 | 0.050 |
Why?
|
Family Therapy | 1 | 1985 | 214 | 0.050 |
Why?
|
Risk Factors | 15 | 2019 | 74971 | 0.050 |
Why?
|
Clothing | 1 | 1984 | 96 | 0.050 |
Why?
|
Gallstones | 1 | 2006 | 285 | 0.050 |
Why?
|
Compulsive Behavior | 1 | 1984 | 117 | 0.050 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2005 | 423 | 0.050 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2024 | 217 | 0.050 |
Why?
|
Drug Interactions | 2 | 2005 | 1421 | 0.050 |
Why?
|
Ambulatory Care | 5 | 1996 | 2783 | 0.050 |
Why?
|
Haloperidol | 1 | 2004 | 394 | 0.050 |
Why?
|
Attitude to Health | 1 | 2011 | 2025 | 0.050 |
Why?
|
Dementia | 1 | 2017 | 2741 | 0.050 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2006 | 304 | 0.050 |
Why?
|
Mentally Ill Persons | 1 | 1982 | 125 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2008 | 1070 | 0.050 |
Why?
|
Age Factors | 7 | 2014 | 18454 | 0.050 |
Why?
|
Huntington Disease | 1 | 1989 | 1147 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2009 | 1190 | 0.050 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2003 | 193 | 0.050 |
Why?
|
Sexuality | 1 | 2003 | 179 | 0.050 |
Why?
|
Urinary Incontinence | 1 | 2006 | 496 | 0.050 |
Why?
|
Psychological Tests | 1 | 2003 | 642 | 0.050 |
Why?
|
Hostility | 1 | 2002 | 185 | 0.050 |
Why?
|
Seizures | 1 | 1994 | 3000 | 0.050 |
Why?
|
Child Behavior Disorders | 1 | 2006 | 813 | 0.050 |
Why?
|
Intelligence | 2 | 2018 | 927 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2015 | 1585 | 0.040 |
Why?
|
Deafness | 1 | 1985 | 462 | 0.040 |
Why?
|
Parents | 1 | 2014 | 3597 | 0.040 |
Why?
|
Cross-Sectional Studies | 6 | 2013 | 26384 | 0.040 |
Why?
|
Certification | 1 | 1983 | 420 | 0.040 |
Why?
|
Personality Tests | 2 | 1990 | 80 | 0.040 |
Why?
|
Anger | 1 | 2002 | 405 | 0.040 |
Why?
|
Disabled Persons | 1 | 2009 | 1210 | 0.040 |
Why?
|
Employment | 2 | 2018 | 1114 | 0.040 |
Why?
|
Cognition | 3 | 2013 | 7080 | 0.040 |
Why?
|
Preventive Psychiatry | 1 | 2019 | 6 | 0.040 |
Why?
|
Psychometrics | 7 | 2015 | 3066 | 0.040 |
Why?
|
Boredom | 1 | 1998 | 6 | 0.040 |
Why?
|
Emotions | 2 | 2023 | 2768 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 1994 | 3743 | 0.040 |
Why?
|
Negativism | 1 | 2018 | 23 | 0.040 |
Why?
|
Remission, Spontaneous | 2 | 2010 | 385 | 0.040 |
Why?
|
Observer Variation | 2 | 2002 | 2623 | 0.040 |
Why?
|
Guilt | 1 | 1998 | 95 | 0.040 |
Why?
|
Gastroesophageal Reflux | 1 | 2006 | 836 | 0.040 |
Why?
|
Body Mass Index | 3 | 2013 | 13054 | 0.040 |
Why?
|
Placebos | 1 | 2002 | 1668 | 0.040 |
Why?
|
Psychiatric Department, Hospital | 2 | 2010 | 133 | 0.040 |
Why?
|
Mental Health | 1 | 2012 | 3275 | 0.040 |
Why?
|
Adolescent Behavior | 1 | 2006 | 1190 | 0.040 |
Why?
|
United States | 6 | 2019 | 73180 | 0.040 |
Why?
|
Salivation | 1 | 1996 | 22 | 0.030 |
Why?
|
Individuality | 1 | 2019 | 307 | 0.030 |
Why?
|
Inpatients | 2 | 2006 | 2570 | 0.030 |
Why?
|
Sertraline | 2 | 1996 | 209 | 0.030 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 1978 | 160 | 0.030 |
Why?
|
Enuresis | 1 | 1996 | 50 | 0.030 |
Why?
|
Mandelic Acids | 1 | 1996 | 46 | 0.030 |
Why?
|
Parasympatholytics | 1 | 1996 | 89 | 0.030 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1996 | 87 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2008 | 4045 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5375 | 0.030 |
Why?
|
Bradycardia | 1 | 1996 | 305 | 0.030 |
Why?
|
Health Care Costs | 2 | 2004 | 3270 | 0.030 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 1994 | 165 | 0.030 |
Why?
|
Anthropometry | 1 | 1998 | 1343 | 0.030 |
Why?
|
Economics, Pharmaceutical | 1 | 1993 | 88 | 0.030 |
Why?
|
Health Behavior | 1 | 2004 | 2649 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2004 | 1947 | 0.030 |
Why?
|
Paranoid Personality Disorder | 1 | 2012 | 7 | 0.030 |
Why?
|
Passive-Aggressive Personality Disorder | 1 | 2012 | 5 | 0.030 |
Why?
|
Disease Progression | 4 | 2012 | 13677 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2008 | 4538 | 0.030 |
Why?
|
Patient Admission | 2 | 2016 | 1369 | 0.030 |
Why?
|
Dependent Personality Disorder | 1 | 2012 | 13 | 0.030 |
Why?
|
Research Design | 1 | 2008 | 6213 | 0.020 |
Why?
|
Probability | 1 | 1997 | 2483 | 0.020 |
Why?
|
Ontario | 2 | 1982 | 403 | 0.020 |
Why?
|
Psychiatry | 1 | 1983 | 1716 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6546 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 1996 | 15662 | 0.020 |
Why?
|
Cerebral Ventriculography | 1 | 1990 | 44 | 0.020 |
Why?
|
Aged | 8 | 2014 | 171790 | 0.020 |
Why?
|
Hip Fractures | 1 | 1978 | 996 | 0.020 |
Why?
|
Quality of Life | 1 | 2011 | 13510 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 1993 | 997 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2012 | 12563 | 0.020 |
Why?
|
Regression Analysis | 3 | 2004 | 6346 | 0.020 |
Why?
|
Sick Role | 1 | 1989 | 229 | 0.020 |
Why?
|
Manuals as Topic | 1 | 1987 | 99 | 0.020 |
Why?
|
India | 1 | 1994 | 2325 | 0.020 |
Why?
|
Delusions | 1 | 1990 | 301 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1998 | 2660 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 18065 | 0.020 |
Why?
|
Self Disclosure | 1 | 2008 | 248 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2915 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 5892 | 0.020 |
Why?
|
Diethylstilbestrol | 1 | 1987 | 85 | 0.020 |
Why?
|
Drug Industry | 1 | 1993 | 793 | 0.020 |
Why?
|
Hallucinations | 1 | 1990 | 375 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1994 | 10778 | 0.020 |
Why?
|
Asthma | 1 | 2006 | 6293 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9094 | 0.020 |
Why?
|
Colitis | 1 | 1995 | 1244 | 0.020 |
Why?
|
Psychoses, Substance-Induced | 1 | 1987 | 98 | 0.020 |
Why?
|
Neurotic Disorders | 1 | 2006 | 77 | 0.020 |
Why?
|
Canada | 2 | 1983 | 2129 | 0.020 |
Why?
|
Hypertension | 1 | 2006 | 8615 | 0.020 |
Why?
|
Long-Term Care | 1 | 2010 | 632 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2006 | 300 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1989 | 916 | 0.020 |
Why?
|
Age of Onset | 2 | 2006 | 3346 | 0.020 |
Why?
|
Individuation | 1 | 1985 | 23 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2013 | 1839 | 0.020 |
Why?
|
Sign Language | 1 | 1985 | 12 | 0.020 |
Why?
|
Stimulation, Chemical | 2 | 1996 | 305 | 0.020 |
Why?
|
Schizoid Personality Disorder | 1 | 2004 | 14 | 0.020 |
Why?
|
Survival Analysis | 2 | 2009 | 10115 | 0.020 |
Why?
|
Sleep | 2 | 2013 | 4820 | 0.020 |
Why?
|
Sleep Stages | 1 | 1989 | 706 | 0.010 |
Why?
|
Socialization | 1 | 2005 | 88 | 0.010 |
Why?
|
Family Health | 1 | 2009 | 1255 | 0.010 |
Why?
|
Adolescent Psychiatry | 1 | 2006 | 165 | 0.010 |
Why?
|
Social Conformity | 1 | 1984 | 39 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2931 | 0.010 |
Why?
|
Attention | 1 | 1994 | 2425 | 0.010 |
Why?
|
Social Environment | 1 | 1989 | 1016 | 0.010 |
Why?
|
Cultural Characteristics | 1 | 1985 | 250 | 0.010 |
Why?
|
Hyperphagia | 1 | 1984 | 139 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5890 | 0.010 |
Why?
|
History, 17th Century | 1 | 1982 | 108 | 0.010 |
Why?
|
Sleep Apnea Syndromes | 1 | 1991 | 984 | 0.010 |
Why?
|
Electroencephalography | 2 | 1989 | 6318 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2990 | 0.010 |
Why?
|
History, 18th Century | 1 | 1982 | 206 | 0.010 |
Why?
|
Logistic Models | 2 | 2009 | 13317 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5455 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1997 | 4542 | 0.010 |
Why?
|
Syndrome | 1 | 2007 | 3274 | 0.010 |
Why?
|
Drug Therapy | 1 | 2004 | 504 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1993 | 5544 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21545 | 0.010 |
Why?
|
Parkinson Disease | 1 | 1994 | 2896 | 0.010 |
Why?
|
Psychopathology | 1 | 2003 | 435 | 0.010 |
Why?
|
Social Support | 1 | 2009 | 2193 | 0.010 |
Why?
|
Body Image | 1 | 1984 | 646 | 0.010 |
Why?
|
Polypharmacy | 1 | 2001 | 307 | 0.010 |
Why?
|
Professional-Patient Relations | 1 | 1983 | 725 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2013 | 20776 | 0.010 |
Why?
|
Drug Combinations | 1 | 2004 | 2088 | 0.010 |
Why?
|
Spouse Abuse | 1 | 1999 | 182 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9682 | 0.010 |
Why?
|
Domestic Violence | 1 | 1999 | 180 | 0.010 |
Why?
|
Psychotherapy, Group | 1 | 2001 | 417 | 0.010 |
Why?
|
Sialorrhea | 1 | 1996 | 25 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 1991 | 8055 | 0.010 |
Why?
|
Joint Prosthesis | 1 | 1978 | 251 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15471 | 0.010 |
Why?
|
Mood Disorders | 1 | 2003 | 1129 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14751 | 0.010 |
Why?
|
Outpatients | 1 | 2004 | 1604 | 0.010 |
Why?
|
Models, Psychological | 1 | 2000 | 826 | 0.010 |
Why?
|
Paroxetine | 1 | 1996 | 181 | 0.010 |
Why?
|
Affective Disorders, Psychotic | 1 | 1996 | 187 | 0.010 |
Why?
|
Sleep, REM | 2 | 1989 | 595 | 0.010 |
Why?
|
Retrospective Studies | 5 | 2002 | 81892 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1987 | 2541 | 0.010 |
Why?
|
Cause of Death | 1 | 2005 | 3721 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 199 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8559 | 0.010 |
Why?
|
Diagnosis, Differential | 3 | 1995 | 13020 | 0.010 |
Why?
|
Perphenazine | 1 | 1991 | 33 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2005 | 3233 | 0.010 |
Why?
|
Clonazepam | 1 | 1991 | 135 | 0.010 |
Why?
|
Quality Control | 1 | 1993 | 836 | 0.010 |
Why?
|
Respiratory Therapy | 1 | 1991 | 125 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2009 | 59738 | 0.000 |
Why?
|
Lithium Carbonate | 1 | 1989 | 179 | 0.000 |
Why?
|
Dilatation, Pathologic | 1 | 1990 | 527 | 0.000 |
Why?
|
Reference Values | 1 | 1993 | 4941 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36861 | 0.000 |
Why?
|
Terminology as Topic | 1 | 1991 | 1541 | 0.000 |
Why?
|
Internship and Residency | 1 | 1983 | 5956 | 0.000 |
Why?
|
Reaction Time | 1 | 1989 | 2102 | 0.000 |
Why?
|
Affect | 1 | 1990 | 1500 | 0.000 |
Why?
|
Weight Gain | 1 | 1991 | 2359 | 0.000 |
Why?
|
Child, Preschool | 1 | 2002 | 42684 | 0.000 |
Why?
|
Infant | 1 | 2000 | 36541 | 0.000 |
Why?
|
Pregnancy | 1 | 1987 | 30175 | 0.000 |
Why?
|